BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Nuvilex Another Biotech Changing the Face of Medical Marijuana


3/15/2013 9:34:40 AM

NEW YORK, NY--(Marketwire - March 14, 2013) - Nuvilex, Inc. (OTCQB: NVLX), an international biotechnology and clinical stage provider of natural products and cell and gene therapy solutions for the treatment of diseases, has established a subsidiary in the Medical Marijuana industry.

Stock House Group, a full service investment relations firm focused on research, awareness and content development takes a look into the company that's giving the Medical Marijuana sector another biotech that will help to legitimize the drug for medicinal purposes.

In the U.S., there has always been a raised eyebrow in the room when it comes to using marijuana for medicinal purposes, but it's slowly eroding with more and more states passing legislation in favor of the use of marijuana for health reasons.

Make no mistake about it, medical marijuana is big business and prescription cannabis is now available in 18 states, the nation's capital, and eleven more states are considering legalizing the drug medically as well. The numbers are staggering -- in this country, we're talking about a $1.7-billion medical marijuana market and growing rapidly.

Marijuana's reputation is well documented and the once raised eyebrow at the mere mention of passing laws allowing its use is now starting to lower a bit as positive press defines the amazing benefits that can be realized from the drug. It will be the research and studies done by biotechnology companies like Nuvilex Inc. (OTCQB: NVLX) subsidiary, Medical Marijuana Sciences, Inc. and Cannabis Science, Inc. that helps change the image of marijuana from solely a drug to a medicine.

When serious diseases like brain, pancreatic, and other forms of cancer are diagnosed, patients aren't too concerned where a cure comes from, so Nuvilex, Cannabis Science and other biotechs are hard at work discovering the medical advantages of marijuana.

Read the full Feature News Article at www.stockhousegroup.com/features

About Stock House Group

Stock House Group is a full service Investment Relations firm specializing in Awareness, Research, and Content Development. The firm offers a platform to CEO's to develop their story through the press, Research Reports, and CEO Interviews. At the same time, we're building a library of Research to assist Investors in their due diligence on micro, small and large cap stocks.


Contact:
Stock House Group
www.stockhousegroup.com
Email Contact
646-397-4020



Read at BioSpace.com

Nuvilex
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES